Kyri K. Van Hoose - Sep 1, 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Chief Financial Officer
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Stock symbol
DRMA
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/1/2021, 08:32 PM
Previous filing
May 14, 2021
Next filing
Jan 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (right to Buy) Award $0 +75K $0.00 75K Sep 1, 2021 Common Stock 75K $5.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 equal monthly installments commencing October 1, 2021.